相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The impact of the COVID-19 pandemic on neurofibromatosis clinical care and research
Heather B. Radtke et al.
ORPHANET JOURNAL OF RARE DISEASES (2021)
Increasing access to specialty care for rare diseases: a case study using a foundation sponsored clinic network for patients with neurofibromatosis 1, neurofibromatosis 2, and schwannomatosis
Vanessa L. Merker et al.
BMC HEALTH SERVICES RESEARCH (2018)
Neurofibromatosis Clinic: A Report on Patient Demographics and Evaluation of the Clinic
Alireza Mansouri et al.
CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES (2017)
Young Australian adults with NF1 have poor access to health care, high complication rates, and limited disease knowledge
Emily C. Oates et al.
AMERICAN JOURNAL OF MEDICAL GENETICS PART A (2013)
Risk of benign tumours of nervous system, and of malignant neoplasms, in people with neurofibromatosis: population-based record-linkage study
O. O. Seminog et al.
BRITISH JOURNAL OF CANCER (2013)
What The Evidence Shows About Patient Activation: Better Health Outcomes And Care Experiences; Fewer Data On Costs
Judith H. Hibbard et al.
HEALTH AFFAIRS (2013)
Emotional functioning of patients with neurofibromatosis tumor suppressor syndrome
Daphne L. Wang et al.
GENETICS IN MEDICINE (2012)
Mortality in neurofibromatosis 1: in North West England: an assessment of actuarial survival in a region of the UK since 1989
D. Gareth R. Evans et al.
EUROPEAN JOURNAL OF HUMAN GENETICS (2011)
Mortality associated with neurofibromatosis type 1: A study based on Italian death certificates (1995-2006)
Maria Masocco et al.
ORPHANET JOURNAL OF RARE DISEASES (2011)
The role of patient activation in frequent attendance at primary care: A population-based study of people with chronic disease
Maria Donald et al.
PATIENT EDUCATION AND COUNSELING (2011)
Clinical and genetic aspects of neurofibromatosis 1
Kimberly Jett et al.
GENETICS IN MEDICINE (2010)
Molecular evolution of a neurofibroma to malignant peripheral nerve sheath tumor (MPNST) in an NF1 patient: correlation between histopathological, clinical and molecular findings
Gill Spurlock et al.
JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY (2010)
Neurofibromatosis type 1 and associated malignancies
Kaleb Yohay
CURRENT NEUROLOGY AND NEUROSCIENCE REPORTS (2009)
Adolescents' transition to self-management of a chronic genetic disorder
Ellen Giarelli et al.
QUALITATIVE HEALTH RESEARCH (2008)
The distinctive biology of cancer in adolescents and young adults
Archie Bleyer et al.
NATURE REVIEWS CANCER (2008)
Further evidence of the increased risk for malignant peripheral nerve sheath tumour from a Scottish cohort of patients with neurofibromatosis type 1
A. McCoughan et al.
JOURNAL OF MEDICAL GENETICS (2007)
Guidelines for the diagnosis and management of individuals with neurofibromatosis 1
Rosalie E. Ferner et al.
JOURNAL OF MEDICAL GENETICS (2007)
Is Patient Activation Associated With Outcomes of Care for Adults With Chronic Conditions?
David M. Mosen et al.
JOURNAL OF AMBULATORY CARE MANAGEMENT (2007)
Retrospective analysis of patients attending a neurofibromatosis type 1 clinic
Fiona Noble et al.
JOURNAL OF PAEDIATRICS AND CHILD HEALTH (2007)
High frequencies of plexiform neurofibromas, mental retardation, learning difficulties, and scoliosis in Brazilian patients with neurofibromatosis type 1
AB Trovó-Marqui et al.
BRAZILIAN JOURNAL OF MEDICAL AND BIOLOGICAL RESEARCH (2005)
Prevalence of neurofibromatosis 1 in German children at elementary school enrollment
M Lammert et al.
ARCHIVES OF DERMATOLOGY (2005)
Malignant peripheral nerve sheath tumours in neurofibromatosis 1
DGR Evans et al.
JOURNAL OF MEDICAL GENETICS (2002)
Cost evaluation of the medical management of neurofibromatosis 1: a prospective study on 201 patients
P Wolkenstein et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
分享论文
